ArticlePharmaceutics2022

Preclinical Evaluation of hnRNPA2B1 Antibody in Human Triple-Negative Breast Cancer MDA-MB-231 Cells via PET Imaging.

Abhinav Bhise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.